CARE in Children Survey

A Survey to Understand Clinicians' Attitudes and Practices in Management of Asthma in Children

DEMOGRAPHIC INFORMATION

Informed Consent:

By proceeding with the survey, you confirm that you have understood the purpose of this survey is to understand the knowledge and attitudes of clinicians towards diagnosis and management of asthma in children and voluntarily agree to participate. Your participation is entirely voluntary, and you may withdraw at any time without any consequences. No personal identifiers will be disclosed and all data will be analyzed in aggregate for research and publication purposes only.

Survey questionnaire:

1. How do you usually confirm diagnosis of asthma in children? (Select all that apply)
< 3 years 3-5 years 6-11 years > 12 years
Physical finding with symptoms
Clinical history and response to bronchodilator
Spirometry (if feasible)
Trial of controller therapy and reassessment
Referral to specialist
Others (please specify)
2. For children with recurrent symptoms and suspected asthma, what is your preferred first-line treatment approach?
< 3 years 3-5 years 6-11 years > 12 years
Daily low-dose ICS
Intermittent high-dose ICS during viral illness
Intermittent high-dose ICS only while symptoms persist
Leukotriene receptor antagonist
SABA monotherapy
Combination of ICS + bronchodilator
Others (please specify)
3. In which situations do you use SABA alone (without a controller) for children? (Select all that apply)
< 5 years 6-11 years > 12 years
First episode of wheeze or suspected asthma
Mild intermittent asthma (symptoms <2 times/week)
Viral-induced wheeze with long symptom-free intervals
While awaiting diagnostic confirmation
Caregiver preference or adherence concerns
Never – I always add a controller (ICS) along with SABA
Other (please specify)
4. What percentage of your pediatric patients with suspected asthma or recurrent wheeze, cough and breathlessness are currently managed with SABA alone?
5. When do you start daily ICS in children? (Choose all that apply for all rows)
< 3 years 3-5 years 6-11 years > 12 years
After ≥3 episodes of wheezing in 12 months
After hospitalization for asthma exacerbation
Persistent symptoms (>2 days/week)
Symptoms interfering with sleep or activity
Frequent need for SABA (e.g., >2 times/week)
After spirometry/ other lung function tests confirm persistent asthma
After trial of reliever-only therapy fails
Others (please specify)
6. What is your usual duration of ICS in confirmed asthma cases (moderate) in the below age groups? (Choose 1 option per row)
< 3 years 3-5 years 6-11 years > 12 years
4 weeks
8-12 weeks
3-6 months
Long-term until symptom-free
Others (please specify)
7. Which is your preferred ICS for management of asthma in children?
8. Which is your preferred device for delivering inhaled medications to children with asthma?
Devices < 3 years 3-5 years 6-11 years > 12 years
MDI with spacer
Nebulizer
Dry powder inhaler
Breath-actuated inhalers
Others (please specify)
9. If initiated, for how long do you typically continue nebulization therapy with ICS in children with asthma?
10. How frequently do you administer ICS along with SABA in the clinic/ hospital during acute asthma exacerbations in children?
11. Apart from asthma, for which conditions do you prescribe inhaled corticosteroids (ICS) in children? (Select all that apply)